← 產業報告目錄
Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Other Antimicrobials and Antibiotics, By Mode Of Delivery, By Animal Type, Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-16頁數 180報告編號 INSIGHTACE-cb2d2114dc
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 4.99 Billion, the global Veterinary Antibiotics Market is expected to expand to USD 6.95 Billion by 2034, demonstrating a CAGR of 3.5% during the 2025–2034 forecast window.
The Veterinary Antibiotics sector involves key industry insights & findings from the report:
The market is in great demand due to the growing number of pet diseases worldwide, which leads to market growth. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Antibiotics Market Snapshot
Chapter 4. Global Veterinary Antibiotics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Key Veterinary Companies
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Major Investment, Partnerships and Collaborations in Veterinary Research
Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Type:
5.2.1. Tetracyclines
5.2.2. Penicillins
5.2.3. Sulfonamides
5.2.4. Macrolides
5.2.5. Aminoglycosides
5.2.6. Lincosamides
5.2.7. Fluoroquinolones
5.2.8. Cephalosporins
5.2.9. Other Antimicrobials and Antibiotics
Chapter 6. Market Segmentation 2: Mode of Delivery Estimates & Trend Analysis
6.1. Mode of Delivery & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Mode of Delivery:
6.2.1. Premixes
6.2.2. Oral Powder
6.2.3. Oral Solution
6.2.4. Injection
6.2.5. Others
Chapter 7. Market Segmentation 3: Animal Type Estimates & Trend Analysis
7.1. Animal Type & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Animal Type
7.2.1. Premixes
7.2.2. Oral Powder
7.2.3. Oral Solution
7.2.4. Injection
7.2.5. Others
Chapter 8. Veterinary Antibiotics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by Product Type, 2024-2031
8.1.2. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by Mode of Delivery, 2024-2031
8.1.3. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Veterinary Antibiotics Market revenue (US$ Million) by Product Type, 2024-2031
8.2.2. Europe Veterinary Antibiotics Market revenue (US$ Million) by Mode of Delivery, 2024-2031
8.2.3. Europe Veterinary Antibiotics Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by Product Type, 2024-2031
8.3.2. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by Mode of Delivery, 2024-2031
8.3.3. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Veterinary Antibiotics Market revenue (US$ Million) by Product Type, (US$ Million) 2024-2031
8.4.2. Latin America Veterinary Antibiotics Market revenue (US$ Million) by Mode of Delivery, 2024-2031
8.4.3. Latin America Veterinary Antibiotics Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by Product Type, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by Mode of Delivery, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by country, (US$ Million) 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bayer AG
9.2.2. Boehringer Ingelheim GmbH
9.2.3. Ceva Sante Animale S.A.
9.2.4. Crystal Pharma
9.2.5. Dechra Pharmaceuticals PLC
9.2.6. Huvepharma AD
9.2.8. Eli Lilly Company
9.2.8. Elanco
9.2.9. Merck & Co., Inc.
9.2.10. Sanofi S.A.
9.2.11. Vetoquinol S.A.
9.2.12. Virbac
9.2.13. Zoetis, Inc.
9.2.14. Inovet Group
9.2.15. Dopharma
9.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們